Selected research
Market Structure
Global EPA and DHA Omega-3 Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global EPA and DHA Omega-3 Ingredients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of EPA and DHA Omega-3 Ingredients include Alaska Omega, Omega Protein Corporation, Cargill, BASF SE, The Archer Daniels Midland Company, Wiley Companies, Novotech Nutraceuticals, Koninklijke DSM and Croda International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global EPA and DHA Omega-3 Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of EPA and DHA Omega-3 Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents EPA and DHA Omega-3 Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA and DHA Omega-3 Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.
EPA and DHA Omega-3 Ingredients Segment by Company
Alaska Omega
Omega Protein Corporation
Cargill
BASF SE
The Archer Daniels Midland Company
Wiley Companies
Novotech Nutraceuticals
Koninklijke DSM
Croda International
Epax Norway AS
Golden Omega SA
KD Pharma Group
Novasep Holding SAS
Lyxia Corporation
EPA and DHA Omega-3 Ingredients Segment by Type
Fish Oil
Algae Oil
Others
EPA and DHA Omega-3 Ingredients Segment by Application
Food and Beverages
Dietary Supplements and Nutraceutical
Infant Formulas
Pharmaceutical and Clinical Nutrition
Animal Feed
Others
EPA and DHA Omega-3 Ingredients Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA Omega-3 Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA Omega-3 Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA Omega-3 Ingredients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the EPA and DHA Omega-3 Ingredients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EPA and DHA Omega-3 Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of EPA and DHA Omega-3 Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of EPA and DHA Omega-3 Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fish Oil
- Algae Oil
- Others
Applications
- Food and Beverages
- Dietary Supplements and Nutraceutical
- Infant Formulas
- Pharmaceutical and Clinical Nutrition
- Animal Feed
- Others
Companies covered
- Alaska Omega
- Omega Protein Corporation
- Cargill
- BASF SE
- The Archer Daniels Midland Company
- Wiley Companies
- Novotech Nutraceuticals
- Koninklijke DSM
- Croda International
- Epax Norway AS
- Golden Omega SA
- KD Pharma Group
- Novasep Holding SAS
- Lyxia Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global EPA and DHA Omega-3 Ingredients Market Size, 2021 VS 2025 VS 2032
- 1.3 Global EPA and DHA Omega-3 Ingredients Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global EPA and DHA Omega-3 Ingredients Sales Estimates and Forecasts (2021-2032)
- 1.5 Global EPA and DHA Omega-3 Ingredients Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global EPA and DHA Omega-3 Ingredients Market Dynamics
- 2.1 EPA and DHA Omega-3 Ingredients Industry Trends
- 2.2 EPA and DHA Omega-3 Ingredients Industry Drivers
- 2.3 EPA and DHA Omega-3 Ingredients Industry Opportunities and Challenges
- 2.4 EPA and DHA Omega-3 Ingredients Industry Restraints
3 EPA and DHA Omega-3 Ingredients Market by Manufacturers
- 3.1 Global EPA and DHA Omega-3 Ingredients Revenue by Manufacturers (2021-2026)
- 3.2 Global EPA and DHA Omega-3 Ingredients Sales by Manufacturers (2021-2026)
- 3.3 Global EPA and DHA Omega-3 Ingredients Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global EPA and DHA Omega-3 Ingredients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global EPA and DHA Omega-3 Ingredients Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global EPA and DHA Omega-3 Ingredients Manufacturers, Product Type & Application
- 3.7 Global EPA and DHA Omega-3 Ingredients Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global EPA and DHA Omega-3 Ingredients Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 EPA and DHA Omega-3 Ingredients Players Market Share by Revenue in 2025
- 3.8.3 2025 EPA and DHA Omega-3 Ingredients Tier 1, Tier 2, and Tier 3
4 EPA and DHA Omega-3 Ingredients Market by Type
- 4.1 EPA and DHA Omega-3 Ingredients Type Introduction
- 4.1.1 Fish Oil
- 4.1.2 Algae Oil
- 4.1.3 Others
- 4.2 Global EPA and DHA Omega-3 Ingredients Sales by Type
- 4.2.1 Global EPA and DHA Omega-3 Ingredients Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global EPA and DHA Omega-3 Ingredients Sales by Type (2021-2032)
- 4.2.3 Global EPA and DHA Omega-3 Ingredients Sales Market Share by Type (2021-2032)
- 4.3 Global EPA and DHA Omega-3 Ingredients Revenue by Type
- 4.3.1 Global EPA and DHA Omega-3 Ingredients Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global EPA and DHA Omega-3 Ingredients Revenue by Type (2021-2032)
- 4.3.3 Global EPA and DHA Omega-3 Ingredients Revenue Market Share by Type (2021-2032)
5 EPA and DHA Omega-3 Ingredients Market by Application
- 5.1 EPA and DHA Omega-3 Ingredients Application Introduction
- 5.1.1 Food and Beverages
- 5.1.2 Dietary Supplements and Nutraceutical
- 5.1.3 Infant Formulas
- 5.1.4 Pharmaceutical and Clinical Nutrition
- 5.1.5 Animal Feed
- 5.1.6 Others
- 5.2 Global EPA and DHA Omega-3 Ingredients Sales by Application
- 5.2.1 Global EPA and DHA Omega-3 Ingredients Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global EPA and DHA Omega-3 Ingredients Sales by Application (2021-2032)
- 5.2.3 Global EPA and DHA Omega-3 Ingredients Sales Market Share by Application (2021-2032)
- 5.3 Global EPA and DHA Omega-3 Ingredients Revenue by Application
- 5.3.1 Global EPA and DHA Omega-3 Ingredients Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global EPA and DHA Omega-3 Ingredients Revenue by Application (2021-2032)
- 5.3.3 Global EPA and DHA Omega-3 Ingredients Revenue Market Share by Application (2021-2032)
6 Global EPA and DHA Omega-3 Ingredients Sales by Region
- 6.1 Global EPA and DHA Omega-3 Ingredients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global EPA and DHA Omega-3 Ingredients Sales by Region (2021-2032)
- 6.2.1 Global EPA and DHA Omega-3 Ingredients Sales by Region (2021-2026)
- 6.2.2 Global EPA and DHA Omega-3 Ingredients Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America EPA and DHA Omega-3 Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America EPA and DHA Omega-3 Ingredients Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe EPA and DHA Omega-3 Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe EPA and DHA Omega-3 Ingredients Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific EPA and DHA Omega-3 Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific EPA and DHA Omega-3 Ingredients Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa EPA and DHA Omega-3 Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa EPA and DHA Omega-3 Ingredients Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global EPA and DHA Omega-3 Ingredients Revenue by Region
- 7.1 Global EPA and DHA Omega-3 Ingredients Revenue by Region
- 7.1.1 Global EPA and DHA Omega-3 Ingredients Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global EPA and DHA Omega-3 Ingredients Revenue by Region (2021-2026)
- 7.1.3 Global EPA and DHA Omega-3 Ingredients Revenue by Region (2027-2032)
- 7.1.4 Global EPA and DHA Omega-3 Ingredients Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America EPA and DHA Omega-3 Ingredients Revenue (2021-2032)
- 7.2.2 North America EPA and DHA Omega-3 Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe EPA and DHA Omega-3 Ingredients Revenue (2021-2032)
- 7.3.2 Europe EPA and DHA Omega-3 Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific EPA and DHA Omega-3 Ingredients Revenue (2021-2032)
- 7.4.2 Asia-Pacific EPA and DHA Omega-3 Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa EPA and DHA Omega-3 Ingredients Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa EPA and DHA Omega-3 Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Alaska Omega
- 8.1.1 Alaska Omega Company Information
- 8.1.2 Alaska Omega Business Overview
- 8.1.3 Alaska Omega EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Alaska Omega EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.1.5 Alaska Omega Recent Developments
- 8.2 Omega Protein Corporation
- 8.2.1 Omega Protein Corporation Company Information
- 8.2.2 Omega Protein Corporation Business Overview
- 8.2.3 Omega Protein Corporation EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Omega Protein Corporation EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.2.5 Omega Protein Corporation Recent Developments
- 8.3 Cargill
- 8.3.1 Cargill Company Information
- 8.3.2 Cargill Business Overview
- 8.3.3 Cargill EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cargill EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.3.5 Cargill Recent Developments
- 8.4 BASF SE
- 8.4.1 BASF SE Company Information
- 8.4.2 BASF SE Business Overview
- 8.4.3 BASF SE EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 BASF SE EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.4.5 BASF SE Recent Developments
- 8.5 The Archer Daniels Midland Company
- 8.5.1 The Archer Daniels Midland Company Company Information
- 8.5.2 The Archer Daniels Midland Company Business Overview
- 8.5.3 The Archer Daniels Midland Company EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 The Archer Daniels Midland Company EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.5.5 The Archer Daniels Midland Company Recent Developments
- 8.6 Wiley Companies
- 8.6.1 Wiley Companies Company Information
- 8.6.2 Wiley Companies Business Overview
- 8.6.3 Wiley Companies EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Wiley Companies EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.6.5 Wiley Companies Recent Developments
- 8.7 Novotech Nutraceuticals
- 8.7.1 Novotech Nutraceuticals Company Information
- 8.7.2 Novotech Nutraceuticals Business Overview
- 8.7.3 Novotech Nutraceuticals EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Novotech Nutraceuticals EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.7.5 Novotech Nutraceuticals Recent Developments
- 8.8 Koninklijke DSM
- 8.8.1 Koninklijke DSM Company Information
- 8.8.2 Koninklijke DSM Business Overview
- 8.8.3 Koninklijke DSM EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Koninklijke DSM EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.8.5 Koninklijke DSM Recent Developments
- 8.9 Croda International
- 8.9.1 Croda International Company Information
- 8.9.2 Croda International Business Overview
- 8.9.3 Croda International EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Croda International EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.9.5 Croda International Recent Developments
- 8.10 Epax Norway AS
- 8.10.1 Epax Norway AS Company Information
- 8.10.2 Epax Norway AS Business Overview
- 8.10.3 Epax Norway AS EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Epax Norway AS EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.10.5 Epax Norway AS Recent Developments
- 8.11 Golden Omega SA
- 8.11.1 Golden Omega SA Company Information
- 8.11.2 Golden Omega SA Business Overview
- 8.11.3 Golden Omega SA EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Golden Omega SA EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.11.5 Golden Omega SA Recent Developments
- 8.12 KD Pharma Group
- 8.12.1 KD Pharma Group Company Information
- 8.12.2 KD Pharma Group Business Overview
- 8.12.3 KD Pharma Group EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 KD Pharma Group EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.12.5 KD Pharma Group Recent Developments
- 8.13 Novasep Holding SAS
- 8.13.1 Novasep Holding SAS Company Information
- 8.13.2 Novasep Holding SAS Business Overview
- 8.13.3 Novasep Holding SAS EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Novasep Holding SAS EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.13.5 Novasep Holding SAS Recent Developments
- 8.14 Lyxia Corporation
- 8.14.1 Lyxia Corporation Company Information
- 8.14.2 Lyxia Corporation Business Overview
- 8.14.3 Lyxia Corporation EPA and DHA Omega-3 Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Lyxia Corporation EPA and DHA Omega-3 Ingredients Product Portfolio
- 8.14.5 Lyxia Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 EPA and DHA Omega-3 Ingredients Value Chain Analysis
- 9.1.1 EPA and DHA Omega-3 Ingredients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 EPA and DHA Omega-3 Ingredients Production Mode & Process
- 9.2 EPA and DHA Omega-3 Ingredients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 EPA and DHA Omega-3 Ingredients Distributors
- 9.2.3 EPA and DHA Omega-3 Ingredients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst